A L Gerbes

Summary

Affiliation: University of Munich
Country: Germany

Publications

  1. ncbi request reprint [Hepatorenal syndrome]
    A L Gerbes
    Medizinische Klinik II, Klinikum der Ludwig Maximilians Universität München Grosshadern, Munich
    Dtsch Med Wochenschr 128:S93-5. 2003
  2. ncbi request reprint [Diagnosis and treatment of ascites]
    A L Gerbes
    Medizinische Klinik II, Klinikum der Ludwig Maximilians Universität Grosshadern, Munchen
    Dtsch Med Wochenschr 129:S63-5. 2004
  3. pmc Evaluation of serum cystatin C concentration as a marker of renal function in patients with cirrhosis of the liver
    A L Gerbes
    Department of Medicine II, Klinikum of the University of Munich Grosshadern, Munich, Germany
    Gut 50:106-10. 2002
  4. ncbi request reprint Successful treatment of chronic Budd-Chiari syndrome with a transjugular intrahepatic portosystemic shunt
    P Michl
    Department of Medicine II, Klinikum Grosshadern, University of Munich, Germany
    J Hepatol 32:516-20. 2000
  5. ncbi request reprint A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites
    M Rossle
    Medizinische Klinik II, Albrecht Ludwigs Universität, Department of Gastroenterology, Freiburg, Germany
    N Engl J Med 342:1701-7. 2000
  6. ncbi request reprint Long-term therapy and retreatment of hepatorenal syndrome type 1 with ornipressin and dopamine
    V Gulberg
    Department of Medicine II, Klinikum Grosshadern, University of Munich, Munich, Germany
    Hepatology 30:870-5. 1999
  7. ncbi request reprint [Renal impairment in liver diseases]
    A L Gerbes
    Medizinische Klinik II, Klinikum der Universitat Munchen Grosshadern, Munchen
    Praxis (Bern 1994) 95:1535-8. 2006
  8. ncbi request reprint [Successful conservative therapy of hepatorenal syndrome with vasopressin-1-receptor antagonist ornipressin]
    V Gulberg
    Medizinische Klinik II, Ludwig Maximilians Universitat, Munchen
    Z Gastroenterol 36:1053-8. 1998
  9. ncbi request reprint [Pharmacological treatment of ascites and hepatorenal syndrome]
    V Gulberg
    Medizinische Klinik II, Klinikum der Ludwig Maximilians Universität München Grosshadern, Munich
    Dtsch Med Wochenschr 128:375-7. 2003
  10. pmc Increased renal production of C-type natriuretic peptide (CNP) in patients with cirrhosis and functional renal failure
    V Gulberg
    Department of Medicine II, Klinikum Grosshadern, University of Munich, Germany
    Gut 47:852-7. 2000

Collaborators

Detail Information

Publications31

  1. ncbi request reprint [Hepatorenal syndrome]
    A L Gerbes
    Medizinische Klinik II, Klinikum der Ludwig Maximilians Universität München Grosshadern, Munich
    Dtsch Med Wochenschr 128:S93-5. 2003
  2. ncbi request reprint [Diagnosis and treatment of ascites]
    A L Gerbes
    Medizinische Klinik II, Klinikum der Ludwig Maximilians Universität Grosshadern, Munchen
    Dtsch Med Wochenschr 129:S63-5. 2004
  3. pmc Evaluation of serum cystatin C concentration as a marker of renal function in patients with cirrhosis of the liver
    A L Gerbes
    Department of Medicine II, Klinikum of the University of Munich Grosshadern, Munich, Germany
    Gut 50:106-10. 2002
    ..Therefore, the aim of this study was to investigate the value of serum cystatin C concentration for the detection of moderately impaired renal function...
  4. ncbi request reprint Successful treatment of chronic Budd-Chiari syndrome with a transjugular intrahepatic portosystemic shunt
    P Michl
    Department of Medicine II, Klinikum Grosshadern, University of Munich, Germany
    J Hepatol 32:516-20. 2000
    ..Therefore, the patient could be removed from the waiting list for liver transplantation. This case demonstrates for the first time that the use of TIPS in chronic Budd-Chiari syndrome may result in marked recovery of liver function...
  5. ncbi request reprint A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites
    M Rossle
    Medizinische Klinik II, Albrecht Ludwigs Universität, Department of Gastroenterology, Freiburg, Germany
    N Engl J Med 342:1701-7. 2000
    ..However, the benefit of this procedure as compared with that of large-volume paracentesis is uncertain...
  6. ncbi request reprint Long-term therapy and retreatment of hepatorenal syndrome type 1 with ornipressin and dopamine
    V Gulberg
    Department of Medicine II, Klinikum Grosshadern, University of Munich, Munich, Germany
    Hepatology 30:870-5. 1999
    ..Thus, ornipressin plus dopamine can be a useful therapeutic option in patients with HRS type 1, especially as bridge to liver transplantation...
  7. ncbi request reprint [Renal impairment in liver diseases]
    A L Gerbes
    Medizinische Klinik II, Klinikum der Universitat Munchen Grosshadern, Munchen
    Praxis (Bern 1994) 95:1535-8. 2006
    ..Patients with HRS type I exhibit a very poor prognosis. Liver transplantation is the only established therapy with long-term success. To bridge the time to transplantation TIPS or terlipressin and albumin can be used...
  8. ncbi request reprint [Successful conservative therapy of hepatorenal syndrome with vasopressin-1-receptor antagonist ornipressin]
    V Gulberg
    Medizinische Klinik II, Ludwig Maximilians Universitat, Munchen
    Z Gastroenterol 36:1053-8. 1998
    ..So far, no noninvasive therapy of hepatorenal syndrome has been established. This is the first report of successful medical treatment of HRS type I with a three-week infusion of the vasopressin-l-receptor agonist ornipressin...
  9. ncbi request reprint [Pharmacological treatment of ascites and hepatorenal syndrome]
    V Gulberg
    Medizinische Klinik II, Klinikum der Ludwig Maximilians Universität München Grosshadern, Munich
    Dtsch Med Wochenschr 128:375-7. 2003
  10. pmc Increased renal production of C-type natriuretic peptide (CNP) in patients with cirrhosis and functional renal failure
    V Gulberg
    Department of Medicine II, Klinikum Grosshadern, University of Munich, Germany
    Gut 47:852-7. 2000
    ..Therefore, the aim of the present study was to investigate the possible role of CNP in renal function disturbances in patients with cirrhosis of the liver...
  11. ncbi request reprint TIPS or vasoconstrictors for the treatment of hepatorenal syndrome type 1--effect on survival?
    V Gulberg
    Department of Medicine II, Klinikum of the Ludwig Maximilians University Grosshadern, Munich, Germany
    Z Gastroenterol 40:823-6. 2002
    ..The present analysis of combined data from these reports shows that this positive effect on renal function also may improve survival of patients with HRS type I...
  12. ncbi request reprint Microcirculatory failure after rat liver transplantation is related to Kupffer cell-derived oxidant stress but not involved in early graft dysfunction
    R J Schauer
    Department of Surgery, Klinikum Grosshadern, University of Munich, Germany
    Transplantation 72:1692-9. 2001
    ..We therefore investigated whether KC induce microcirculatory disturbances through ROS release and whether microcirculatory failure contributes to early graft function after liver transplantation...
  13. ncbi request reprint [52-year-old patient with subcutaneous space-occupying lesion in immunosuppression]
    F T Kolligs
    Medizinische Klinik II, Klinikum Grosshadern, Ludwig Maximilians Universitat Munchen
    Internist (Berl) 44:740-5. 2003
    ..Furthermore, HCV reinfection (genotype 2b) was successfully treated with interferone alpha 2b and ribavirine for 6 months...
  14. ncbi request reprint Tumour size is an important predictor for the outcome after liver transplantation for hepatocellular carcinoma
    F Löhe
    Department of Surgery, Ludwig Maximilians University of Munich, Klinikum Grosshadern, Marchioninistr 15, D 81377 Munich, Germany
    Eur J Surg Oncol 31:994-9. 2005
    ..Recently, there is a tendency to expand tumour sizes qualifying for OLT. The present study re-evaluates tumour size and histopathological features as selection criteria for OLT...
  15. ncbi request reprint [Acute liver failure in nefazodone therapy? A case report]
    S Ehrentraut
    Psychiatrische Klinik und Poliklinik der LMU München, Nussbaumstrasse 7, 80336 Munchen
    Nervenarzt 73:686-9. 2002
    ..Six weeks after initiation of therapy with nefazodone, he developed fatal liver failure. After cessation of the drug, the patient did not recover. He underwent liver transplantation but unfortunately died...
  16. ncbi request reprint [Ascites, spontaneous bacterial peritonitis and hepatorenal syndrome]
    A L Gerbes
    Medizinische Klinik II, Klinikum Grosshadern der Universität München
    Dtsch Med Wochenschr 130:S237-9. 2005
  17. ncbi request reprint [Advances in therapy for ascites and hepatorenal syndrome]
    A L Gerbes
    Medizinische Klinik II, Klinikum der Ludwig Maximilians Universität, Grosshadern, Munchen
    Z Gastroenterol 43:31-4. 2005
    ..Patients with hepatorenal syndrome seem to benefit from a combination of terlipressin and albumin whereas the effect of albumin dialysis on survival remains to be proven...
  18. ncbi request reprint Transjugular intrahepatic portosystemic shunting is not superior to endoscopic variceal band ligation for prevention of variceal rebleeding in cirrhotic patients: a randomized, controlled trial
    V Gulberg
    Dept of Medicine II and Institute for Clinical Radiology, Klinikum of the University of Munich Grosshadern, Munich, Germany
    Scand J Gastroenterol 37:338-43. 2002
    ..The aim of the present study was to compare the transjugular intrahepatic portosystemic shunt (TIPS) with variceal band ligation (VBL) in the prophylaxis of variceal rebleeding in patients with cirrhosis of the liver...
  19. ncbi request reprint Endothelin and endothelin receptor antagonism in portopulmonary hypertension
    W Neuhofer
    Department of Physiology University of Munich, Munich, Germany
    Eur J Clin Invest 36:54-61. 2006
    ..If these observations can be corroborated by controlled clinical trials, bosentan would offer several advantages over available therapies, which have major drawbacks owing to their invasive and demanding mode of application...
  20. ncbi request reprint Acute postinfectious glomerulonephritis associated with Campylobacter jejuni enteritis - a case report and review of the literature on C. jejuni's potential to trigger immunologically mediated renal disease
    M op den Winkel
    Department of Medicine II, University Hospital Munich Großhadern, Ludwig Maximilians University, Munich, Germany
    Clin Nephrol 74:474-9. 2010
    ..However, long-term prognosis remains unclear. In addition to the case report, we conducted a review of the literature with results underlining Campylobacter jejuni's potential to trigger various types of immune mediated kidney diseases...
  21. ncbi request reprint Atrial natriuretic peptide reduces expression of TNF-alpha mRNA during reperfusion of the rat liver upon decreased activation of NF-kappaB and AP-1
    A K Kiemer
    Department of Medicine II, Klinikum Grosshadern, University of Munich, Germany
    J Hepatol 33:236-46. 2000
    ..The identification of the mechanisms underlying the protection by ANP should reveal new aspects concerning the pathomechanisms of ischemia/reperfusion injury...
  22. ncbi request reprint Short-term effects of statin therapy in patients with hyperlipoproteinemia after liver transplantation: results of a randomized cross-over trial
    R Zachoval
    Medical Department II, Klinikum Grosshadern, Ludwig-Maximilians-University, Munich, Germany
    J Hepatol 35:86-91. 2001
    ..CONCLUSIONS: Low-dose cerivastatin and pravastatin significantly improve lipid profiles following liver transplantation without affecting liver function or immunosuppression...
  23. doi request reprint JNK inhibition sensitises hepatocellular carcinoma cells but not normal hepatocytes to the TNF-related apoptosis-inducing ligand
    S R Mucha
    University of Munich, University Hospital Grosshadern, Department of Medicine II, Research Lab B 5 E01 308, Marchioninistrasse 15, D 81377 Munich, Germany
    Gut 58:688-98. 2009
    ..In this study we investigated whether JNK activity in HCC could contribute to the resistance to apoptosis in these tumours...
  24. ncbi request reprint [Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage]
    M Bilzer
    Medizinische Klinik II, Klinikum Grosshadern, Ludwig Maximilians Universitat, Munchen
    Z Gastroenterol 40:543-4. 2002
  25. ncbi request reprint Elevated arterial compliance in patients with cirrhosis is not related to arterial endothelin-1
    S Møller
    Dept of Clinical Physiology, Hvidovre Hospital, University of Copenhagen, Denmark
    Scand J Gastroenterol 37:1064-9. 2002
    ..As ET-1 may be manipulated by somastostatin, the study includes infusion of octreotide in a subset of patients...
  26. ncbi request reprint Q-T interval (QT(C)) in patients with cirrhosis: relation to vasoactive peptides and heart rate
    J H Henriksen
    Department of Clinical Physiology 239 and Gastroenterology 439, H S Hvidovre Hospital, University of Copenhagen, Denmark
    Scand J Clin Lab Invest 67:643-53. 2007
    ..The aim of this study was to relate QT to the circulating level of endothelins (ET-1 and ET-3) and calcitonin gene-related peptide (CGRP) in patients with cirrhosis. In addition, we studied problems with HR correction of QT...
  27. ncbi request reprint [Aspiration of ascites]
    V Gulberg
    Dtsch Med Wochenschr 132:2594; author reply 2594. 2007
  28. ncbi request reprint Increased arterial compliance in cirrhosis is related to decreased arterial C-type natriuretic peptide, but not to atrial natriuretic peptide
    J H Henriksen
    Dept of Clinical Physiology, Hvidovre Hospital, University of Copenhagen, Denmark
    Scand J Gastroenterol 38:559-64. 2003
    ..The aim of the present study was to relate COMPart with arterial levels of the circulating natriuretic peptides: atrial natriuretic peptide (ANP) and C-type natriuretic peptide (CNP), both of which are vasodilators...
  29. ncbi request reprint Hepatitis induced by Noni juice from Morinda citrifolia: a rare cause of hepatotoxicity or the tip of the iceberg?
    B Yuce
    Department of Internal Medicine II, Ludwig Maximilians University of Munich, Germany
    Digestion 73:167-70. 2006
    ..After cessation of the Noni juice ingestion, her transaminase levels normalized quickly and were in the normal range within 1 month...
  30. pmc Effects of the neutral endopeptidase inhibitor thiorphan on cardiovascular and renal function in cirrhotic rats
    K S Park
    Liver Unit, Gastroenterology Research Group, University of Calgary, 3330 Hospital Drive NW, Calgary, Alberta, Canada T2N 4N1
    Br J Pharmacol 139:81-8. 2003
    ..7. We conclude that thiorphan induces natriuresis in cirrhotic rats by a direct renal medullary mechanism via cGMP and Na(+) - K(+) ATPase, without affecting systemic hemodynamics. This may potentially be useful in patients with ascites...
  31. pmc Differential gene expression of the three natriuretic peptides and natriuretic peptide receptor subtypes in human liver
    A M Vollmar
    Institute of Pharmacology, Toxicology and Pharmacy, Ludwigs Maximilians University of Munich, Germany
    Gut 40:145-50. 1997
    ..Various effects of atrial natriuretic peptide (ANP) on the liver have been observed. However, there is limited information about the types of receptors for natriuretic peptides expressed by the human liver...